Advertisement

The Immune Response in Human Demyelinating Diseases

  • Hans Link
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 100)

Summary

Lymphocytes present in the brain, meninges and cerebrospinal fluid (CSF) in multiple sclerosis (MS) are capable of synthesizing IgG. The CSF in MS contains more T-lymphocytes and fewer B-lymphocytes compared to blood. The reactivity of CSF lymphocytes in MS to T-cell mitogens and probably also to a combined B-and T-cell mitogen is absent or heavily reduced. This unresponsiveness of CSF lymphocytes may be a consequence of their previous activation. The blood lymphocytes in MS are not altered regarding distribution of B-and T-cells, nor regarding responsiveness to mitogens, when compared with healthy controls. An asynchronous synthesis of heavy and light immunoglobulin chains occurs within the CNS in many MS patients, giving rise to oligoclonal band patterns on electrophoresis and abnormal kappa/lambda light chain ratios of CSF.

The synthesized immunoglobulins are most probably antibodies which may play a role in the pathogenesis and course of human demyelinating diseases. The brain must be regarded, from an immunological point of view, as a privileged site with its own immune system and its characteristic immune reactions, and future research concerning demyelinating diseases should, if possible, include investigations of these reactions.

Keywords

Multiple Sclerosis Multiple Sclerosis Patient Subacute Sclerosing Panencephalitis Measle Antibody Light Chain Ratio 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams, C.W.M., Pathology of multiple sclerosis: progression of the lesion, Brit. Med. Bull. 33 (1977) 15–20.Google Scholar
  2. 2.
    Brown, P., Cathala, F., Gajdusek, D.C. and Gibbs, C.J., Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis, Proc. Soc. Exp. Biol. Med. 137 (1971) 956–961.PubMedGoogle Scholar
  3. 3.
    Felgenhauer, K., Protein size and cerebrospinal fluid composition, Klin. Wschr. 52 (1971+) 1158–1164.Google Scholar
  4. 4.
    Frick, E. and Scheid-Seydel, L., Untersuchungen mit J131-markiertem y-Globulin zur Frage der Abstammung der Liquoreiweisskörper, Klin. Wschr. 36 (1958) 857-863.Google Scholar
  5. 5.
    Frydén, A. and Link, H., Mitogen stimulation of cerebrospinal fluid lymphocytes in aseptic meningitis, Acta Neurol. Scandinay. submitted for publication (1977).Google Scholar
  6. 6.
    Kabat, E.A., Moore, D.H. and Landow, H., An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins, J. Clin. Invest. 21 (1942) 571–577.Google Scholar
  7. 7.
    Kam-Hansen, S., Frydén, A. and Link, H., Lymphocyte sub-populations and the effect of mitogen stimulation in multiple sclerosis, Acta Neurol. Scandinay., submitted for publication (1977).Google Scholar
  8. 8.
    Laterre, E.C., Callewaert, A. and Heremans, J.F., Electrophoretic morphology of gammaglobulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system, Neurology 20 (1970) 982–990.PubMedCrossRefGoogle Scholar
  9. 9.
    Laurell, C.B., Determination and interpretation of plasma proteins, Austr. Fam. Phys. 5 (1976) 36–41.Google Scholar
  10. 10.
    Link, H., Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid: Chemical and immunological characterisation with special reference to multiple sclerosis,Acta Neurol. Scandinay. 43, Suppl. 28 (1967) 1–136.Google Scholar
  11. 11.
    Link, H., Oligoclonal immunoglobulin G in multiple sclerosis brains, J. neurol. Sci. 16 (1972) 103–114.PubMedCrossRefGoogle Scholar
  12. 12.
    Link, H., Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome, Acta Neurol. Scandinay. 52 (1975) 111–120.Google Scholar
  13. 13.
    Link, H. and Müller, R., Immunoglobulins in multiple sclerosis and infections of the nervous system, Arch. Neurol. 25 (1971) 326–344.Google Scholar
  14. 14.
    Link, H., Panelius, M. and Salmi, A.A., Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis, Arch. Neurol. 28 (1973) 23-30.Google Scholar
  15. 15.
    Link, H. and Tibbling, G., Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid, Scand. J. Lab. Clin. Invest., in press.Google Scholar
  16. 16.
    Link, H. and Tibbling, G., Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis, Scand. J. Lab. Clin. Invest., in press.Google Scholar
  17. 17.
    Link, H. and Zettervall, 0., Multiple sclerosis: disturbed kappa:lambda chain ratio of immunoglobulin G in cerebrospinal fluid, Clin. exp. Immunol. 6 (1970) 435–438.Google Scholar
  18. 18.
    Norrby, E., Link, H. and Olsson, J.-E., Measles virus antibody titers in cerebrospinal fluid and serum from patients with multiple sclerosis and controls, Arch. Neurol. 30 (1974) 285–292.Google Scholar
  19. 19.
    Norrby,E.,Link, H.,Olsson,J.-E.,Panelius,M.,Salmi,A.and Vandvik,B.,Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis, Infection and Immunity 10 (1974) 688694.Google Scholar
  20. 20.
    Olsson, J.-E. and Link, H., Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters. Exacerbations and remissions, Arch. Neurol. 28 (1973) 392-399.Google Scholar
  21. 21.
    Olsson, J.-E., Link, H. and Müller, R., Immunoglobulin abnormalities in multiple sclerosis, J. neurol. Sci. 27 (1976) 233–245.PubMedCrossRefGoogle Scholar
  22. 22.
    Sandberg-Wollheim, M., Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis, Scand. J. Immunol. 3 (1974) 717–730.Google Scholar
  23. 23.
    Sandberg-Wollheim, M. and Turesson, I., Lymphocyte subpopulations in the cerebrospinal fluid and peripheral blood in patients with multiple sclerosis, Scand. J. Immunol. 4 (1975) 831–836.Google Scholar
  24. 24.
    Tibbling, G., Link, H. and Obman, S., Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values, Scan. J. Clin. Invest., in press.Google Scholar
  25. 25.
    Tourtellotte, W.W., Multiple sclerosis research, in Proceedings of a joint conference held by the Medical Research Council and the Multiple Sclerosis Society of Great Britain and Northern Ireland, 17–18 October 1974 (A.N. Davison, J.H. Humphrey, L.H. Liversedge, W.J. McDonald and J.S. Porterfield, eds.) HMSO, London (1975) pp. 9-26.Google Scholar
  26. 26.
    Vandvik, B., Natvig, J.B. and Wiger, D., IgG, subclass restriction of oligoclonal IgG from cerebrospinal fluids and brainextracts in patients with multiple sclerosis and subacute encephalitides, Scand. J. Immunol. 5 (1976) )427-436.Google Scholar
  27. 27.
    Vandvik, B., Norrby, E., Nordal, H.J. and Degré, M., Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis, Scand. J. Immunol. 5 (1976) 979–992.Google Scholar
  28. 28.
    Yahr, M.D., Goldensohn, S.S. and Kabat, E.A., Further studies on the gamma globulin content of cerebrospinal fluid in multiple sclerosis and other neurological disorders, Ann. N.Y. Acad.Sci. 58 (1954) 613–624Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Hans Link
    • 1
  1. 1.Department of NeurologyUniversity HospitalLinköpingSweden

Personalised recommendations